Abstract  Description  Claims  Drawing  Search report  Cited references 

US61986578   [0001] 

Enantiomers, Racemates and Resolutions   [0076] 
Vogel's Textbook of Practical Organic Chemistry   [0103] 
March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure   [0103] 
Advanced Organic Chemistry: Part B: Reaction and Synthesis   [0105] 
Physicians' Desk Reference   [0107] 
Approved Drug Products with Therapeutic Equivalence Evaluations   [0107] 
Pharmaceutical Salts   [0108] 
7 Modern Pharmaceutics   [0116] 
Pharmaceutical Dosage Forms: Tablets   [0116] 
Introduction to Pharmaceutical Dosage Forms   [0116] 
Remington's Pharmaceutical Sciences   [0116] 
Advances in Pharmaceutical Sciences   [0116] 
Advances in Pharmaceutical Sciences   [0116] 
Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms   [0116] 
Pharmaceutical Particulate Carriers: Therapeutic Applications: Drugs and the Pharmaceutical Sciences   [0116] 
Drug Delivery to the Gastrointestinal Tract   [0116] 
Modem Pharmaceutics Drugs and the Pharmaceutical Sciences   [0116] 
Remington's Pharmaceutical Sciences   [0122] 
New therapeutic targets in atrophic age-related macular degeneration   [0388] 
Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects   [0388] 
RPE lipofuscin in ageing and age-related macular degeneration   [0388] 
Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration   [0388] 
Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells   [0388] 
Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration   [0388]  [0388] 
Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration   [0388] 
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope   [0388] 
A2E, a byproduct of the visual cycle   [0388] 
Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases   [0388] 
Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivo   [0388] 
In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences   [0388] 
N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats   [0388] 
Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats   [0388] 
Fenretinide activates caspases and induces apoptosis in gliomas   [0388] 
Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines   [0388] 
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide   [0388] 
Classical and novel retinoids: their targets in cancer therapy   [0388]  [0388] 
N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153   [0388]  [0388] 
Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites   [0388] 
Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells   [0388] 
The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration   [0388] 
Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation   [0388] 
Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration   [0388] 
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein   [0388] 
Synthetic retinoid fenretinide in breast cancer chemoprevention   [0388] 
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials   [0388] 
A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors   [0388] 
Unique properties of coactivator recruitment caused by differential binding of FK614, an anti-diabetic agent, to PPARgamma   [0388] 
Nuclear receptors have distinct affinities fo coactivators: characterization by FRET   [0388] 
Binding affinities of retinol and related compounds to retinol binding proteins   [0388] 
Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface   [0388] 
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer   [0388] 
Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis   [0388] 
Retinol-Binding Protein Levels are Increased in Association with Gonadotropin Levels in Healthy Women   [0388] 
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes   [0388] 
The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model   [0388] 
Novel Lipofuscin Bisretinoids Prominent in Human Retina and in a Model of Recessive Stargardt Disease   [0388] 
Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration   [0388]